A Gynecologic Oncology Group phase II study of amonafide (NSC 308847) in epithelial ovarian cancer.

v1

Type:Journal Article

0 views

[![NobleID](https://www.nobleid.org/api/badge/DB87FEF3.svg?ark=w1%2F20260515%2FDB87FEF3)](https://nobleid.org/work/w1/20260515/DB87FEF3)

ARK Inflections

Bibliometric Analysis

Impact metrics, research fronts, co-authorship networks →

Authors & Claims

Paper Authors